Vancomycin-Belpharm 500 mg

An antibiotic of the glycopeptide group. It has a bactericidal effect. It disrupts the synthesis of the cell wall, the permeability of the cytoplasmic membrane and the synthesis of bacterial RNA. It is active against gram-positive bacteria: Staphylococcus spp. (including strains producing penicillinase and methicillin-resistant strains), Streptococcus spp., Enterococcus spp., Corynebacterium spp., Listeria spp., Actinomyces spp., Clostridium spp. (including Clostridium difficile). No cross-resistance with antibiotics of other groups has been noted.

Indications for the active ingredients of the drug:

• Severe infectious and inflammatory diseases caused by pathogens sensitive to vancomycin (with intolerance or ineffectiveness of therapy with other antibiotics, including penicillins or cephalosporins): sepsis, endocarditis (as monotherapy or as part of combination antibiotic therapy), pneumonia, lung abscess, meningitis, bone and joint infections, skin and soft tissue infections. Pseudomembranous colitis caused by Clostridium difficile.